Scott Mahan
Impact in
-
- Antibiotic Resistance in Bacteria
Papers in
-
- SARS-CoV-2 detection and testing 2
-
- Gut microbiota and health 2
- Genetics, Bioinformatics, and Biomedical Research 1
- Co-authors
- Michael J. Mahan (6 shared papers)Douglas M. Heithoff (6 shared papers)Lucien Barnes (5 shared papers)John K. House (4 shared papers)Jeffrey Fried (4 shared papers)Gary N. Fox (2 shared papers)Kristin Ardlie (2 shared papers)Gang Li (1 shared paper)
- Journals
- EBioMedicine (3 papers)Assay and Drug Development Technologies (1 paper)JAMA Network Open (1 paper)The American Journal of Human Genetics (1 paper)Cell Reports Medicine (1 paper)
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Scott Mahan
11 papers receiving 299 citations
Peers
Comparison fields: 5 of 81
- Drug Discovery 1
- Molecular Medicine 28
- Infectious Diseases 69
- Applied Microbiology and Biotechnology 7
- Endocrinology 16
Countries citing papers authored by Scott Mahan
This map shows the geographic impact of Scott Mahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Mahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Mahan more than expected).
Fields of papers citing papers by Scott Mahan
This network shows the impact of papers produced by Scott Mahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Mahan. The network helps show where Scott Mahan may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Mahan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 88 | |
| 2 | 2022 | 41 | |
| 3 | 2022 | 38 | |
| 4 | 2018 | 28 | |
| 5 | 2024 | 28 | |
| 6 | 2023 | 25 | |
| 7 | 2023 | 19 | |
| 8 | 2023 | 18 | |
| 9 | 2022 | 10 | |
| 10 | 2004 | 9 | |
| 11 | 2021 | 2 |
About Scott Mahan
Scott Mahan is a scholar working on Infectious Diseases, Molecular Biology, Pharmacology, Clinical Biochemistry and Molecular Medicine, having authored 11 papers that have together received 306 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Biosensors and Analytical Detection (2 papers), SARS-CoV-2 detection and testing (2 papers), Gut microbiota and health (2 papers), Antibiotic Resistance in Bacteria (2 papers), Antibiotic Use and Resistance (2 papers) and Genetics, Bioinformatics, and Biomedical Research (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Molecular Medicine (28 citations), Infectious Diseases (69 citations), Applied Microbiology and Biotechnology (7 citations) and Endocrinology (16 citations). Scott Mahan has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Michael J. Mahan, Douglas M. Heithoff, Lucien Barnes, John K. House, Jeffrey Fried, Gary N. Fox, Kristin Ardlie, Gang Li, Peter Szolovits and Lynn Bry. Their work appears in journals such as EBioMedicine, Assay and Drug Development Technologies, JAMA Network Open, The American Journal of Human Genetics and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.